Brompheniramine/Phenylephrine

DEA Class; Rx

Common Brand Names; Brovex PB, Respahist-II, Vazotab Chewable, Children’s Dimetapp Cold & Allergy

  • Antihistamine/Decongestant Combos

Oral combination of an antihistamine and nasal decongestant
Used for the temporary relief of symptoms due to allergic rhinitis or other respiratory allergies or the common cold
May cause increased blood pressure and/or sedation; excitability may occur, especially in children

Indicated for the temporary relief of symptoms due to seasonal allergic rhinitis or the common cold, including sneezing, rhinorrhea, itching of the nose and throat, nasal congestion, and itchy, watery eyes.

Hypersensitivity to brompheniramine or phenylephrine

Use within 14 days of MAO therapy

Sedation of children

Breast feeding of newborn

Severe CAD or hypertension

Acute asthma attack

Urinary retention

Peptic ulcer

Phenylephrine (Common)

  • Hypertension, reflex bradycardia
  • Anxiety, dizziness, excitability, headache, nervousness, restlessness
  • Rebound congestion, sneezing, pulmonary edema
  • Brompheniramine (Common)

Anticholinergic effects (blurred vision, dry mouth/nose, throat)

  • Drowsiness, dizziness, decreased coordination, headache
  • Constipation, stomach upset

May impair mental abilities (CNS depression)

Caution on CAD, diabetes mellitus, BPH, pyloroduodenal obstruction, respiratory disease, thyroid dysfunction

Pregnancy category: C; not recommended in first tri-mester or last 2 weeks of pregnancy

Lactation: Contraindicated

Adults

24 mg/day PO brompheniramine and 60 mg/day PO phenylephrine.

Geriatric

24 mg/day PO brompheniramine and 60 mg/day PO phenylephrine.

Adolescents

24 mg/day PO brompheniramine and 60 mg/day PO phenylephrine.

Children

12 years: 24 mg/day PO brompheniramine and 60 mg/day PO phenylephrine.
6 to 11 years: 12 mg/day PO brompheniramine and 30 mg/day PO phenylephrine.
1 to 5 years: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

Brompheniramine/phenylephrine

tablet, chewable

  • 6mg/15mg

oral suspension

  • (6mg/10mg)/5mL
  • (1.2mg/2mg)/1mL

oral liquid

  • (1mg/2.5mg)/5mL
  • (2mg/5mg)/5mL

elixir

  • (1mg/2.5mg)/5mL

About the Author

You may also like these

0